Thank you, Robert. With these results, our strong backlog, and the largest maintenance portfolio in the industry, we are confident that our strategy will continue to deliver attractive results in 2026 ...
Biosimilars pipeline and portfolio fueling growth: – with the second-largest portfolio and most biosimilars launched across the industry since 2020.2 4 innovative product submissions targeted over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results